# Molecular Characterization of CTCs and ctDNA in Blood and Plasma Samples From Patients With Metastatic and/or Hormone-Resistant Prostate Cancer

> **NCT02370355** · — · TERMINATED · sponsor: **University of Southern California** · enrollment: 24 (actual)

## Conditions studied

- Hormone-Resistant Prostate Cancer
- Metastatic Prostate Carcinoma

## Interventions

- **OTHER:** Cytology Specimen Collection Procedure
- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT02370355
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2014-12-23
- **Primary completion:** 2016-06-08
- **Final completion:** 2016-06-08
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Sponsor decided not to pursue study
- **Last updated:** 2017-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02370355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02370355, "Molecular Characterization of CTCs and ctDNA in Blood and Plasma Samples From Patients With Metastatic and/or Hormone-Resistant Prostate Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02370355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*